BeOne Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	19,178	22,491	26,689	27,797	9,022
Short-Term Investments	-	-	4,588	14,261	21,340
Cash & Short-Term Investments	19,178	22,491	31,278	42,058	30,362
Cash Growth	-14.73%	-28.09%	-25.63%	38.52%	343.72%
Accounts Receivable	4,936	2,539	1,194	3,069	394.35
Other Receivables	239.61	268.45	178.06	108.39	125.81
Receivables	5,176	2,807	1,372	3,177	520.15
Inventory	3,613	2,951	1,947	1,541	582.96
Prepaid Expenses	360.33	625.83	573.1	881.82	376.93
Restricted Cash	67.97	81.35	1.35	2.08	2
Other Current Assets	740.22	850.02	742.45	707.15	541.92
Total Current Assets	29,135	29,806	35,914	48,368	32,386
Property, Plant & Equipment	12,538	10,065	6,593	4,479	2,927
Long-Term Investments	941.09	635.66	633.02	640.29	322.15
Goodwill	-	-	-	0.69	0.71
Other Intangible Assets	372.95	405.16	280.14	296.53	32.64
Long-Term Deferred Tax Assets	-	-	-	-	430.64
Other Long-Term Assets	230.34	253.27	578.75	438.51	466.04
Total Assets	43,217	41,165	43,999	54,223	36,565
Accounts Payable	2,956	2,234	2,033	1,667	1,514
Accrued Expenses	5,697	4,431	3,311	3,394	2,545
Short-Term Debt	5,963	4,678	2,171	2,698	2,185
Current Portion of Long-Term Debt	252.42	202.67	97.51	17.94	2
Current Portion of Leases	128.29	155.65	165.82	139.28	90.71
Current Income Taxes Payable	189.27	162.74	173.73	135.91	133.05
Current Unearned Revenue	-	-	1,475	1,191	-
Other Current Liabilities	980.93	970.18	700.7	918.13	549.73
Total Current Liabilities	16,167	12,835	10,129	10,161	7,020
Long-Term Debt	1,215	1,401	1,443	1,284	1,199
Long-Term Leases	323.18	157.78	238.07	273.42	192.05
Long-Term Unearned Revenue	221.34	242.54	553.17	1,694	320.81
Long-Term Deferred Tax Liabilities	306.61	116.96	110.33	90.01	70.46
Other Long-Term Liabilities	542.26	1,222	1,240	1,713	2,450
Total Liabilities	18,895	16,082	13,766	15,265	11,304
Common Stock	1.01	0.96	0.93	0.84	0.77
Additional Paid-In Capital	88,231	82,245	79,600	71,092	48,409
Retained Earnings	-62,822	-56,458	-48,835	-32,249	-23,194
Comprehensive Income & Other	-1,087	-705.16	-533.96	114.03	45.32
Total Common Equity	24,322	25,083	30,233	38,958	25,261
Shareholders' Equity	24,322	25,083	30,233	38,958	25,261
Total Liabilities & Equity	43,217	41,165	43,999	54,223	36,565
Total Debt	7,882	6,596	4,115	4,413	3,669
Net Cash (Debt)	11,296	15,895	27,162	37,645	26,694
Net Cash Growth	-28.94%	-41.48%	-27.85%	41.03%	443.48%
Net Cash Per Share	107.28	152.27	263.37	405.73	319.79
Filing Date Shares Outstanding	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	106.72	104.58	104.32	102.68	91.6
Working Capital	12,968	16,971	25,786	38,207	25,367
Book Value Per Share	227.91	239.85	289.81	379.42	275.77
Tangible Book Value	23,949	24,678	29,953	38,660	25,227
Tangible Book Value Per Share	224.41	235.97	287.13	376.52	275.40
Land	477.98	464.35	451.66	416	-
Buildings	4,437	1,643	1,534	915.3	728.12
Machinery	3,541	2,781	2,308	1,511	1,145
Construction In Progress	4,774	5,252	2,025	1,187	560.02
Leasehold Improvements	472.11	426.33	370.97	319.46	245.76

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.